Advanced biotherapeutics, including cell, gene, and nucleic-acid therapies, create high-stakes decision and optimization challenges across development, manufacturing, and clinical translation. This one-day workshop brings together advanced-therapy practitioners, quantum computing researchers, HPC/AI teams, technology providers, and translational stakeholders to identify practical, near- to medium-term opportunities for hybrid quantum-classical workflows in real-world biotherapeutic settings.